REBECCA SMITH: Open Payments
NPI 1124670641 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 19 payments from 13 companies in 2025. Trend: 2023 $177 · 2024 $295 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| NxStage Medical, Inc. | 1 | $138 |
| Fresenius USA Marketing, Inc. | 1 | $96 |
| Calliditas Therapeutics US Inc. | 3 | $78 |
| Amgen Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| GENZYME CORPORATION | 1 | $40 |
| Medtronic, Inc. | 1 | $29 |
| Travere Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
Products named: LIBERTY SELECT CYCLER, VELPHORO, TARPEYO, JARDIANCE, KRYSTEXXA, FABRAZYME, SYMPLICITY G3, Ozempic.
Industry payments across NC — which companies pay providers there.
